fda warning letters glp-1 compounders september 2025 Targets and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Issues Warnings Against Illegal

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors

Medication has given me my life back

Measures were taken to minimise pain and discomfort of the animals in accordance with the Directive 40/2013 (II.14): On animal experiments issued by the Government of Hungary, and the Directive 2010/63/EU On the protection of animals used for scientific purposes issued by the European Parliament and the European Council